Telomir Pharmaceuticals, Inc | WebDisclosure

Basculer en Français

9472	Companies
185370	Keywords
117721	Articles
99262	Press releases

Headlines Articles Press releases Telomir Pharmaceuticals, Inc

Home
Companies
Telomir Pharmaceuticals, Inc

BRIEF

published on 10/23/2025 at 13:35, 1 month 12 days ago

Telomir Pharmaceuticals Unveils Promising Preclinical Data for Telomir-1

Prostate Cancer Telomir-1 DNA Methylation CASP8 GSTP1
PRESS RELEASE

published on 10/23/2025 at 13:30, 1 month 12 days ago

Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Resets Cancer's “Kill-and-Clean” Defense Systems in an Aggressive Prostate Cancer Model, Outperforming Rapamycin and Chemo
Telomir Pharmaceuticals reports new findings on Telomir-1's impact on CASP8 and GSTP1 genes, highlighting potential in cancer therapy through DNA methylation modulation

Cancer Therapy Telomir-1 Telomir Pharmaceuticals DNA Methylation Epigenetic Modulation
BRIEF

published on 10/21/2025 at 13:35, 1 month 14 days ago

Telomir Pharmaceuticals Secures Global Rights to Telomir-1

Oncology Market Expansion Telomir-1 Epigenetic Therapy Global Rights
BRIEF

published on 10/21/2025 at 13:35, 1 month 14 days ago

Telomir Pharmaceuticals obtient les droits mondiaux sur Telomir-1

Oncologie Expansion Du Marché Telomir-1 Thérapie Épigénétique Droits Mondiaux
PRESS RELEASE

published on 10/21/2025 at 13:30, 1 month 14 days ago

Telomir Pharmaceuticals Executes Binding LOI for Worldwide Rights to Telomir-1, Positioning the Company for Global Market Expansion and Value Growth
Telomir Pharmaceuticals strengthens global IP rights with acquisition of TELI Pharmaceuticals to expand shareholder contributions and advance investigational therapy, Telomir-1

Telomir-1 Telomir Pharmaceuticals Global IP Rights Shareholder Contributions Investigational Therapy
BRIEF

published on 10/14/2025 at 14:05, 1 month 21 days ago

Telomir Pharmaceuticals Reports Progress in Pancreatic Cancer Research

Pancreatic Cancer Biotechnology Research Telomir-1 Epigenetic Regulation Cancer Cell Survival
BRIEF

published on 10/14/2025 at 14:05, 1 month 21 days ago

Telomir Pharmaceuticals annonce des progrès dans la recherche sur le cancer du pancréas

Cancer Du Pancréas Telomir-1 Régulation Épigénétique Survie Des Cellules Cancéreuses Recherche En Biotechnologie
PRESS RELEASE

published on 10/14/2025 at 14:00, 1 month 21 days ago

Telomir Pharmaceuticals Announces New Data Showing That Telomir-1 Kills Aggressive Pancreatic Cancer Cells, One of the Deadliest Forms of Cancer
Telomir Pharmaceuticals announces new laboratory findings showing Telomir-1's impact on aggressive pancreatic cancer cells, revealing potential therapeutic pathways for treatment

Pancreatic Cancer Telomir-1 Telomir Pharmaceuticals Laboratory Findings Therapeutic Pathways
BRIEF

published on 10/09/2025 at 13:35, 1 month 26 days ago

Telomir Pharmaceuticals Unveils Breakthrough Against Aggressive Breast Cancer

Telomir-1 Telomir Pharmaceuticals Epigenetic Therapy Triple-negative Breast Cancer Iron Regulation
BRIEF

published on 10/09/2025 at 13:35, 1 month 26 days ago

Telomir Pharmaceuticals dévoile une avancée majeure contre le cancer du sein agressif

Telomir-1 Telomir Pharmaceuticals Thérapie Épigénétique Cancer Du Sein Triple Négatif Régulation Du Fer

Accesswire

Published on 12/05/2025 at 02:35, 4 hours 56 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 5 hours 1 minute ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 6 hours 31 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 26 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 31 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 07:00, 31 minutes ago

Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 1 minute ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 40 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 6 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 16 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

Les Echos

Published on 12/04/2025 at 18:14, 13 hours 16 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 31 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 31 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 46 minutes ago

Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 46 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE